At 82, former U.S. President Joe Biden received a diagnosis that stunned the nation. On Friday, medical tests confirmed he is battling aggressive prostate cancer with bone metastasis, according to an official statement from his team. The announcement, made public on Sunday, May 18, 2025, followed Biden’s reports of urinary symptoms that prompted medical attention. The severity of the case, marked by a Gleason score of 9, places the former leader in a critical moment of his storied career.
The diagnosis came after a detailed evaluation at a Philadelphia hospital, where Biden spent the night for additional tests. The discovery of a prostate nodule during a routine physical exam triggered the investigation that led to the cancer confirmation. The news sparked an outpouring of support from allies and even political adversaries, with public figures across the spectrum sending messages of solidarity.
While the diagnosis is alarming, Biden’s medical team emphasized that the cancer is hormone-sensitive, opening pathways to effective treatment options. The former president and his family are consulting with specialists to determine the next steps. Key points about the case include:
Former President Joe Biden was diagnosed with an "aggressive form" of prostate cancer, which has spread to his boneshttps://t.co/e6PgHd575l pic.twitter.com/E7OTDJqcqI
— CNN (@CNN) May 18, 2025
- Severity of diagnosis: A Gleason score of 9 indicates high-risk prostate cancer with rapid spread potential.
- Bone metastasis: The disease has spread to the bones, classifying it as stage IV.
- Treatment possibilities: Hormone sensitivity suggests therapies targeting hormones may slow progression.
- Health history: Biden previously faced skin cancer in 2023, with lesions successfully removed.
Biden’s health, a topic of scrutiny during his presidency as the oldest U.S. president to leave office in January 2025, returns to the forefront as he navigates this serious condition.
Immediate reactions to the diagnosis
The announcement of Biden’s diagnosis sent ripples through the U.S. political and social landscape. Prominent figures, including Republican Congresswoman Marjorie Taylor Greene, expressed solidarity. Greene, a vocal supporter of President Donald Trump, took to X to send “prayers” to Biden and his family, referencing her own loss of her father to cancer in 2021. Her message marked a rare moment of unity in a polarized political climate.
Other leaders, such as former President Barack Obama, also voiced support, praising Biden’s resilience throughout his career. Health organizations, like the American Cancer Society, seized the moment to underscore the importance of early prostate cancer detection, particularly for men over 50. Biden’s high-profile case may drive greater awareness of the disease, which affects roughly 1 in 8 men in the United States.
Medical details of prostate cancer
Biden’s prostate cancer is classified as high-risk due to its Gleason score of 9, a system that evaluates the aggressiveness of cancer cells on a scale from 6 to 10. A score of 9 indicates that the tumor cells differ significantly from normal cells, signaling a higher likelihood of spread. The confirmed bone metastasis places the disease at stage IV, the most advanced stage.
The prostate, a walnut-sized gland below the bladder, plays a key role in semen production. Prostate cancer is the second most common cancer among men, behind skin cancer, according to the Cleveland Clinic. While many cases grow slowly and cause minimal symptoms, aggressive forms, like Biden’s, require immediate intervention. The hormone sensitivity of Biden’s tumor is a positive factor, as therapies that block male hormones, such as testosterone, can slow disease progression.
The urinary symptoms that led Biden to seek medical care, such as increased frequency, are common in older men and can stem from benign conditions like prostate enlargement or from cancer. The detection of a nodule during a routine physical underscores the value of regular check-ups, especially for men in Biden’s age group.
Biden’s health history
Joe Biden has faced other health challenges during his public life. In February 2023, while still president, he underwent a procedure to remove a chest lesion diagnosed as basal cell carcinoma, a common form of skin cancer. The procedure was successful, and the lesion posed no risk of spreading. Prior to his presidency, Biden also had non-melanoma skin cancers removed using Mohs surgery, a precise technique for eliminating cancerous tissue.
In November 2021, a benign but potentially pre-cancerous polyp was removed from his colon during a colonoscopy. These incidents, though less severe than the current diagnosis, highlight the ongoing medical oversight Biden has received. His age, 82, places him in a higher-risk group for various conditions, including prostate cancer, which sees sharply increased incidence in men over 50.
How prostate cancer is diagnosed
Prostate cancer diagnosis typically begins with routine screenings, such as the prostate-specific antigen (PSA) test or digital rectal exam. In Biden’s case, the identification of a prostate nodule during a physical exam prompted further tests, including a biopsy and imaging to assess the disease’s extent. The biopsy, which examines prostate tissue samples, confirmed cancerous cells and established the Gleason score.
Key diagnostic methods include:
- PSA test: Measures levels of a protein produced by the prostate, which may be elevated in cancer or benign conditions.
- Digital rectal exam: Allows doctors to feel for abnormalities, such as nodules, in the prostate.
- Biopsy: Tissue sampling for microscopic analysis, critical for confirming cancer.
- Imaging tests: MRI or CT scans help detect metastases, as seen in Biden’s case.
- Gleason score: Assesses cancer aggressiveness based on cell appearance.
Early detection is vital, as prostate cancer in its initial stages is highly treatable, with survival rates up to 97% when caught early, per Prostate Cancer UK.
Available treatment options
Biden’s hormone-sensitive prostate cancer can be managed with therapies that lower testosterone levels, which fuel cancer cell growth. Hormone therapy is often paired with other treatments, like radiation or chemotherapy, depending on the disease’s spread. For bone metastasis, drugs like bisphosphonates or denosumab may strengthen bones and reduce complications.
Surgery, such as radical prostatectomy, is less common in advanced cases like Biden’s but may be considered in specific scenarios. Targeted radiation can also alleviate symptoms from metastases. Biden’s medical team is evaluating these options, prioritizing treatments that balance effectiveness with quality of life.
Treatment decisions will hinge on factors like Biden’s overall health, the cancer’s progression rate, and initial therapy responses. The hormone sensitivity of the tumor is encouraging, as such cases often respond better to treatment, even in advanced stages.
Prostate cancer prevalence in the U.S.
Prostate cancer is a major health concern for men in the United States. The Centers for Disease Control and Prevention (CDC) report that about 13 in 100 men will develop the disease in their lifetime. In 2021, roughly 237,000 new cases were diagnosed, and over 33,000 men died from the disease in 2022.
Risk factors include:
- Age: Risk rises significantly after age 50.
- Family history: Men with first-degree relatives diagnosed face higher odds.
- Race: Black men have higher incidence and mortality rates.
- Diet: High saturated fat intake may increase risk.
While most cases are slow-growing, aggressive forms like Biden’s pose significant challenges to healthcare systems.
Media and social media response
Biden’s diagnosis dominated news outlets and social media on Sunday, May 18. Posts on X reflected concern, support, and discussions about public figures’ health. Users shared details about prostate cancer’s severity, while others emphasized preventive screenings. The hashtag #BidenHealth trended on X, garnering thousands of mentions within hours of the announcement.
Outlets like CNN, Reuters, and The New York Times published in-depth reports, focusing on the bone metastasis and Gleason score of 9. Coverage also highlighted Biden’s prior health issues, including his 2023 skin cancer procedures. The case reignited debates about transparency in leaders’ health, especially after reports of Biden downplaying age-related concerns in a recent book.
Importance of early detection
Biden’s experience underscores the critical need for regular screenings, particularly for men over 50. Prostate cancer detected early has high cure rates. Organizations like the Prostate Cancer Foundation recommend PSA tests and digital rectal exams starting at age 45, or earlier with a family history.
Awareness campaigns, such as Movember, encourage men to overcome stigmas around prostate exams and prioritize health. Biden’s widely publicized case may spur greater participation in screenings, potentially saving lives.
Health of former presidents in focus
The health of former U.S. presidents often draws public attention, especially for serious conditions like cancer. Cases like Jimmy Carter’s metastatic melanoma and Bill Clinton’s heart procedures illustrate how leaders’ health remains a focal point post-tenure. Biden’s age and historic role as the oldest president to leave office amplify scrutiny.
Transparency about Biden’s health during his presidency faced questions, particularly after the June 2024 presidential debate, which led to his withdrawal from the re-election race. The current diagnosis, though post-presidency, rekindles discussions about how leaders’ health is communicated.
Advances in prostate cancer treatment
Recent years have seen significant progress in prostate cancer treatment, even for advanced cases. New therapies, like immunotherapies and targeted drugs, offer hope for patients with metastases. Clinical trials have shown that combining hormone therapy with other treatments can extend survival in men with metastatic prostate cancer.
Advanced imaging, like positron emission tomography (PET), enables more precise metastasis detection, supporting tailored treatments. These innovations may benefit Biden, whose medical team has access to cutting-edge technology.
Biden family’s response
Biden’s family, including First Lady Jill Biden and children Hunter and Ashley, is closely involved in treatment decisions. Jill Biden, an advocate for health causes like breast cancer prevention, is expected to play a central role in supporting the former president. The family has chosen to keep treatment details private but indicated Biden is approaching the disease with determination.
Consultations with specialists are ongoing, and Biden’s team pledged updates as treatment progresses. The family’s resilience, shaped by past tragedies like the loss of Beau Biden to brain cancer in 2015, is seen as a source of strength.
Timeline of recent events
The events leading to Biden’s diagnosis unfolded quickly:
- Early May 2025: Routine physical exam detects a prostate nodule.
- Mid-May: Additional tests, including a biopsy, conducted in Philadelphia.
- May 16: Results confirm prostate cancer with Gleason score of 9 and bone metastasis.
- May 18: Biden’s team announces the diagnosis publicly.
This timeline highlights the speed of the case’s progression and the importance of swift medical responses.
